Showing results (81-90 of 8,519) with videos related to

Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|October 1, 1990
Effects of PGE2, carbenoxolone, cholecystokinin, and the thromboxane-mimetic U46619 on protein and glycoprotein production by isolated pig gastric mucosal cellsH K Heim, A Oestmann, K F Sewing
Alimentary Pharmacology & Therapeutics|October 1, 1990
Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugsT M Shallcross, B J Rathbone, J I Wyatt, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1990
Some effects of tripotassium dicitrato bismuthate on gastric secretion and the mucus barrierR L Sidebotham, J J Batten, K Li, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
Tripotassium dicitrato bismuthate enemas in the treatment of ulcerative proctitisE D Srivastava, G L Swift, S Wilkinson, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
Effect of enprostil on the gastroduodenal mucosa of healthy volunteersF L Lanza, M G Robinson, J I Isenberg, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
In-vivo anti-reflux and raft properties of alginatesJ R Lambert, M G Korman, L Nicholson, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
A comparison between enprostil and ranitidine in the management of gastric ulcerationA G Morgan, C Pacsoo, P Taylor, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2011
Low exposure to sunlight is a risk factor for Crohn's diseaseV Nerich, P Jantchou, M-C Boutron-Ruault, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2011
Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndromeS Zakko, G Barton, E Weber, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2011
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirinA A Butt, T Umbleja, J W Andersen, et al.
Pageof 852